本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

20.07
-0.0800-0.40%
盤後20.180.1100+0.55%18:14 EST
成交量:162.72萬
成交額:3,275.07萬
市值:25.66億
市盈率:116.41
高:20.39
開:20.21
低:19.75
收:20.15
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.76
換手率:2.08%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:6.93
市盈率(LYR):116.41

資料載入中...

2021/02/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/26

重要事件披露

8-K - Current report
2021/01/07

重要事件披露

8-K - Current report
2021/01/04

重要事件披露

8-K - Current report
2020/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/27

重要事件披露

8-K - Current report
2020/07/30

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/01

重要事件披露

8-K - Current report
2020/05/13

重要事件披露

8-K - Current report
2020/05/07

重要事件披露

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
2020/04/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/06

重要事件披露

Current report, item 5.02
2020/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans